MET and head and neck squamous cell carcinoma: Therefore, we aimed to investigate the comprehensive immune-modulatory effects of the combination regimen in our established humanized mice models of HNSCC and lung squamous cell carcinoma (LUSC) harboring EGFR and/or MET expression.